Abstract
A novel atorvastatin conjugate was synthesized by a multistep procedure, using a branched N-acetylgalactosamine ligand for asialoglycoprotein receptor targeting. The molar solubility of the synthesized conjugate was 6.1 ± 0.9 mM, which is almost 60 times higher compared to unmodified atorvastatin. The hydrolysis products of the conjugate demonstrated effective inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.

This publication has 13 references indexed in Scilit: